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Campylobacter concisus is an emerging pathogen that causes gastroenteritis and 
is a suspected cause of inflammatory bowel diseases. Its importance is enhanced 
by the chronic sequela that results from acute infection. This bacterium has been 
under-diagnosed in intestinal infectious diseases, and its clinical importance has 
not been determined yet. In order to establish the implication of this emerging bac-
terial species in human gastroenteritis and other infections, different approaches 
and procedure have been performed, where molecular typing methods have played 
a central role. The chapter provides a comprehensive past and recent updates on the 
detection of C. concisus by biochemical and molecular methods.
Keywords: Campylobacter concisus, hydrogen-requiring microaerophilic, 
opportunistic pathogen, PCR, PCR-DGGE, MALDI-TOF
1. Introduction
Campylobacter concisus is a fastidious, microaerophilic and hydrogen-requiring 
mesophile. It is a Gram-negative curved rod bacterium that is normally found in 
the human oral cavity and is actively motile with a single polar flagellum [1] with 
a cell size of (0.5–1) × (2–6) μm [2]. This small, non-pigmenting, asaccharolytic 
bacterium [3] usually grows slowly and requires enriched media. Such character-
istics could be linked to its small genome that has a low G + C content (34% -38%) 
[3]. Unlike other Campylobacter spp., C. concisus does not have any known primary 
animal reservoir yet. Probably the human gastrointestinal tract is its only habitat 
where potential infections may spread via the inter-personal route. However it is 
worth to note that C. concisus was reported to be isolated from slaughtered porcine 
samples but not from live animals [4], while its DNA has been detected in few 
animal sources, such as the saliva of domestic pets using PCR-DGGE method [5], 
and in diarrheic faecal samples from domestic dogs by quantitative PCR [6].
Historically, in 1981 Tanner et al. [3] first recognised C. concisus as a member of 
the microflora of the oral cavity. Oral cavity parts are lips, buccal mucosa, teeth, 
gums, tongue, the floor of the mouth below the tongue, and the hard bony roof 
and soft palate. Twenty years later, in addition to its status as a coloniser of the oral 
cavity in humans, C. concisus (with other Campylobacter spp.) was considered as an 
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opportunistic pathogen under certain medical conditions by Macuch, Tanner [7]. 
Since the recognition, there have been many approaches to detect and isolate this 
bacterium, but it remains unclear whether C. concisus is an opportunistic pathogen 
of inflamed tissues, an oral pathogen, or is simply a commensal of the oral cavity. 
Here we focus on past and current isolation and detection techniques used to detect 
this bacterium in clinical samples and other sites of the human’s gastrointesti-
nal tract.
2. C. concisus in the oral cavity
Several studies examined the composition of the subgingival microbiota of chil-
dren and found that the detection rate of C. concisus in permanent teeth is signifi-
cantly higher than that of indeciduous teeth (p < 0.001) [8, 9]. The prevalence of 
C. concisus in the human oral cavity was detected by a PCR targeting the 16S rRNA 
gene and it was found in 100% (11/11) of saliva samples collected from healthy 
individuals [5]. Similar outcomes have been reported by Dewhirst et al. [10], when 
both cultivation and molecular methods were used to identify the human’s oral 
microbiota. Another study conducted by Zhang et al. [11] also suggested that C. 
concisus was commonly present in the human oral cavity. The study reported the 
isolation of C. concisus from saliva of healthy controls, where 75% (44/59) were 
culture positive and 97% (57/59) were PCR positive. It is worth to mention here 
that our research team has successfully isolated this bacterium from 100% healthy 
human adults, using conventional culture and molecular techniques (unpublished 
data). These collective data indicate that the human oral cavity is the primary 
colonisation site of this bacterium.
The association of C. concisus with human periodontal diseases is also well 
reported [3, 9, 12], for example this bacterium was found attached to the teeth in 
higher numbers than other sites of the oral cavity in patients with periodontitis [13]. 
Immune responses against C. concisus in persons with periodontal diseases were also 
investigated, with higher antibody levels detected in periodontally diseased subjects 
compared to healthy controls [14]. Yet in other studies the bacterium was reported 
to be associated with gingivitis, periodontal sites in addition to healthy sites [15].  
C. concisus was also reported to be detected in bleeding sites more than non-bleed-
ing sites in periodontitis [8, 9, 16], and in enlarged lesions of gingivitis [17]. The 
same group reported in a later study that it was more associated with periodontitis 
in smokers than non-smokers participants [18]. The association of C. concisus with 
periodontitis was also supported by significantly higher isolation rates when gingi-
val crevicular fluids (GCF) of patients were positive for aspartate aminotransferase 
(AST) compared to patients with negative result for AST [19]. Later, C. concisus was 
included into one of the six successional complexes that are believed to be involved 
in periodontal diseases [20].
3.  C. concisus in acute gastroenteritis and chronic gastrointestinal 
diseases
The correlation between C. concisus and gastroenteritis was first reported in 
1989 by Vandamme et al. [21]. C. concisus along with other Campylobacter spp. 
such as C. upsaliensis, C. hyointestinalis, and C. fetus have been reported as caus-
ative agents of gastroenteritis, but the bacterium remained unidentified when 
conventional culture techniques with antibiotics in the culture medium were used 
[22–24]. The introduction of hydrogen to the microaerophilic incubation conditions 
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significantly improved the isolation rates of C. concisus from patients with diarrhoea 
[25]. In 1995 a study in Sweden reported that 6% of the total cases of children with 
diarrhoea were found to be related to C. concisus [26]. Another study conducted 
in the same year, in Melbourne, reported that 56% of the “Campylobacter like 
organisms” isolated from children with diarrhoea, were identified to be C. concisus 
by conventional culture techniques [27]. The identity of these isolates was also 
confirmed by molecular techniques in a following study which concluded that C. 
concisus was associated with diarrhoea particularly in infants between 0–35 months 
of age [28]. Van Etterijck et al. [29] did not report a significant difference in C. 
concisus isolation rate from children with and without diarrhoea (9% in control 
and 13.2% in patients). However, other studies reported that this bacterium is 
associated with gastroenteritis cases in children [30–32]. Furthermore, C. concisus 
DNA has been detected in stool samples of patients with gastroenteritis in several 
studies [24, 33–36], with Nielsen et al. [37] reporting the incidence of C. concisus 
in patients with gastroenteritis, almost as high as the common C. jejuni or C. coli in 
a population-based study in Denmark. A more recent study associated C. concisus 
with travellers’ diarrhoea in Nepal using 16S rRNA PCR of Campylobacter [38].
C. concisus was linked to inflammatory bowel diseases (IBD) since 2009 [11] 
when it was first isolated from stool samples of IBD patients [39]. Furthermore, 
Zhang et al. [11] found a significantly higher prevalence of C. concisus in children 
with CD than in controls (p < 0.001). In 2010, C. concisus DNA was detected in fae-
cal samples of CD patients, in a significantly higher ratio (65%) than that of healthy 
and non-IBD controls (33%) [40]. Hence, in 2011, C. concisus was considered to be 
associated with UC cases [41]. Furthermore, the prevalence of C. concisus DNA was 
significantly higher in biopsy specimens (p = 0.0019) of adult UC patients (33.3%) 
as compared with controls (10.8%), which was supported by another study in the 
same year [42]. Ismail et al. [43] compared enteric and oral C. concisus isolates from 
eight patients with IBD (four UC and four CD) and six controls by multi-locus 
sequence typing (MLST), invasion assays, protein analysis, and scanning electron 
microscopy. Interestingly, the MLST results showed that the majority (87.5%) of 
C. concisus isolates from IBD patients were in one cluster compared to those from 
the control group (28.6%) (p < 0.05). This study provided the first evidence that 
patients with IBD are colonised with specific oral C. concisus strains and these 
strains may undergo natural recombination. Exotoxin 9, a putative virulence factor 
which may be associated with increased survival in the cell [44], and the zonula 
tight junction occludens toxin (Zot) [45] have been associated with virulence 
properties of C. concisus isolates from IBD cases.
4. Identification
4.1  Laboratory diagnosis, isolation, and detection of C. concisus in clinical 
specimens
Since C. concisus is usually present with other commensal microorganisms, the 
filtration culture techniques and/or molecular identification methods are more 
reliable than standard culture methods.
4.2 Culture and incubation conditions
C. concisus is routinely cultured on Columbia agar base or blood agar base 
supplemented with 5–6% defibrinated horse blood (HBA) in a special gas mixture 
containing 7% H2, 7% CO2, 5–7% O2 and ~ 79% N2 in an anaerobic jar incubated 
Campylobacter
4
for 48–72 hours at 37 °C [28, 46, 47]. The microaerophilic growth conditions can 
also be generated by evacuating an anaerobic jar to −7 bar and then gassing with a 
mixture of 10% H2, 10% CO2 and ~ 80% N2 [46, 47]. C. concisus appears on HBA as 
colonies measuring 1–2 mm in diameter, round, entire, semi translucent and grey in 
colour [28].
4.3 Identification by cultural and biochemical properties
As C. concisus is a fastidious slow growing bacterium that is biochemically inert 
or inactive, it has been under-reported due to difficulties in isolation and improper 
identification. Sensitivity to cephalothin and nalidixic acid, growth temperature 
and colony colour have been used to identify C. concisus [48]. Arylsulfatase activ-
ity test is another important test, used to differentiate it from C. mucosalis and C. 
upsaliensis [49]. C. concisus was misidentified as C. mucosalis when initially isolated 
from samples other than the oral cavity [21]. Now, C. concisus is reported more 
often from patients with diarrhoea and other sites because of improvement of the 
culture system and the use of the stool filtration technique named the “Cape Town 
Protocol” [50]. In Cape Town, South Africa, the identification rate was reported to 
be increased by 31% when this technique was used with incubation in a hydrogen-
enriched environment [31, 51]. However, as mentioned earlier, recently Nielsen et 
al. [52] demonstrated the polycarbonate filter is superior to the cellulose acetate 
filter for detection of C. concisus.
The phenotypic characteristics used to identify C. concisus in several studies are 
listed in Table 1.
Test [3] [2] [53] [54]
Active motility + + + +
Oxidase + + (60–93%) + V
Catalase — — — —
Urease — — — NA
Hippurate hydrolysis NA — — —
Benzidine reaction +
Indoxyl acetate hydrolysis NA — — —
Nitrate reduction + + (14–50%) + (−)




Benzyl viologen reduction + NA NA
Neutral red reduction + NA NA
Growth at 25 °C NA — —
Growth at 42 °C NA + (60–93%) — (+)
Growth stimulated by formate and fumarate + NA NA
Alpha-hemolysis NA NA —
MacConkey agar NA NA —
Nutrient agar — NA —
Growth on minimal media — — NA
NaCl (2.0%) NA + (14–50%) NA —
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4.4 Isolation from clinical samples
There is no standard technique for the isolation of C. concisus from faeces, saliva 
or tissue. However, the most common technique used to isolate this bacterium 
from faeces is the ‘Cape Town protocol’, which involves filtration of samples onto 
enriched media such as HBA containing antibiotics or onto antibiotic free HBA 
[31, 32]. Initially the faecal sample is suspended in liquid medium or phosphate 
buffered saline (PBS) at 1:2 to 1:10, then, 4–5 drops are placed on a cellulose acetate 
filter (pores size 0.65 μm) positioned on HBA. The soaked filter should be kept 
on the medium for approximately 10 min to allow the small sized bacterial cells to 
pass through its pores. Once the filter is discarded, a streak dilution of the primary 
inoculum is performed then the plate is incubated for 3–5 days in the gas mixture 
conditions as previously explained [46].
To isolate C. concisus from tissue samples such as intestinal biopsies, the 
homogenised sample is spread on HBA plates containing 10 mg/ml of each trim-
ethoprim and vancomycin prior to incubation under the suitable growth conditions 
[11, 42]. Alternatively, a two-step enrichment-filtration method can be used [55] as 
follows: Step 1, the biopsy is enriched by initial incubation for 48 h in microaero-
philic conditions in a tube containing 3 ml of Ham’s F-12 medium with foetal bovine 
serum (5% FBS) and 10 μg/ml of vancomycin; step 2, filtration of 200 μl of the 
enrichment broth from the growth mixture obtained from step 1 onto HBA medium 
containing 10 μg/ml of vancomycin; followed by incubation in similar growth 
conditions for 2–4 days [55].
The isolation of C. concisus from saliva samples can be achieved by streaking 6 μl 
of saliva on a HBA medium containing 10 μg/ml vancomycin and incubation under 
the above mentioned growth condition for 3 days. The mixed bacterial culture is 
then collected as a suspension in BHI broth and filtered using cellulose filter (pores 
size 0.65 μm) on a fresh HBA plate and incubated for 2 days [56]. However, this 
method might not reflect the original load of C. concisus in saliva due to potential 
further growth during both incubation periods. Furthermore, commensals that are 
resistant to vancomycin could also compete and reduce the growth of C. concisus.
5. Detection and confirmation by molecular methods
Historically, C. concisus has been identified based on conventional methods such 
as culturing. This technique poses many challenges and can provide false negative 
results due to several external factors. Molecular biology allows more reliability as 
Test [3] [2] [53] [54]
Glycine (1.0%) NA NA —
Safranin (0.02%) + + (14–50%) NA v
Sodium deoxycholate (0.1%) + + (14–50%) NA —
Nalidixic acid (32 mg/ml) + + (60–93%) R +
Cephalothin (32 mg/ml) NA NA S —
Metronidazole (4 mg/ml) MIC: 0.5–2 + (14–50%) NA —
bTrace quantities, (−) most strains are negative, (+) most strains are positive, v variable, R Resistant, S Sensitive, 
NA not available.
Table 1. 
Biochemical characteristics of C. concisus.
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well as a higher sensitivity when detecting the presence or absence of the pathogens. 
Therefore, a variety of molecular methods have been developed to detect C. con-
cisus. For a bacterium of a fastidious nature, like C. concisus, molecular techniques 
can improve detection and identification in clinical samples. However, genetic 
variations should be considered in these detection methods otherwise some strains 
might be missed.
5.1 Direct detection of DNA in clinical samples
The presence of C. concisus DNA was investigated directly in faeces, intestinal 
biopsy, and saliva samples [11, 35, 56]. Initially a primer set (C412F and C1288R) 
designed by Linton et al. [22] to amplify the 16S rDNA gene (816 bp), was used 
as one step PCR to detect C. concisus from colonic biopsies [11]. Then, to identify 
C. concisus, the PCR product was sequenced and aligned to published sequences 
[11]. Soon after, a specific nested PCR was developed by Man et al. [40] to detect 
C. concisus in faecal specimens targeting the 16S rDNA gene. In the first PCR step, 
the primer set (C412F and C1288R) designed by Linton et al. [22], was used, while 
in the second step a new primer set (ConcisusF and ConcisusR) was developed to 
amplify a specific 560 bp region from the first PCR product of the 16S rDNA gene. 
Man et al. [40] applied this PCR to detect C. concisus from children’s stool samples 
with CD, non-IBD patients and healthy controls. Later, this nested PCR method was 
also applied to detect C. concisus from saliva samples collected from IBD patients 
and healthy controls [56]. This nested PCR has been used for C. concisus DNA 
detection in other human clinical specimens including intestinal biopsies and saliva 
[40–42, 56].
Later on, Huq et al. [35] developed a multiplex PCR (m-PCR) to detect C. 
concisus and other campylobacter spp.. in faecal samples, based on the size of PCR 
product. When this m-PCR was applied on spiked faecal samples, C. concisus, C. 
jejuni, and C. coli were specifically identified at 105 cells/gm of faeces. However, as 
C. concisus is present in very low numbers in intestinal samples, using the nested 
PCR could be more sensitive than the m-PCR method.
5.2 Molecular confirmation and typing
The first specific PCR used for C. concisus identification was developed in 1995 
by Bastyns et al. [57] using the forward primer MUC1 and a mix of two reverse 
primers CON1/CON2 to amplify the 23S rDNA region of C. concisus isolates. In 
2004, we modified the this PCR method used by Bastyns et al. [57] to identify and 
group 19 clinical isolates from children with diarrhoea into two genomospecies 
using primers MUC1/CON1 (genomospecies A) and MUC1/CON2 (genomospecies 
B) [28]. However, there were some reports on that the primers designed for this 
PCR constantly cross reacted with C. showae and Wolinella succinogenes and pro-
duced a similar size PCR product [31].
Other techniques which successfully identified C. concisus were later developed 
including a two-step identification scheme for Campylobacter, Arcobacter and 
Helicobacter based on analysis of the 16S rRNA gene by PCR-RFLP (PCR-restriction 
fragment length polymorphism) by Marshall et al. [58]. Another PCR assay was 
developed, in 2001, from a 1.6 kb DNA fragment isolated from C. concisus genomic 
library for molecular identification, where a single PCR product was obtained without 
any cross reaction from other Campylobacter spp. [51]. Another primer set (Pcisus5-F 
and Pcisus6-R) developed by Matsheka et al. [51] was initially used to amplify DNA 
fragments (344 bp) obtained from a C. concisus genomic library and later showed to 
specifically amplify C. concisus [28, 35, 51]. This primer set amplifies gyrB [35].
7
Conventional and Molecular Detection Methods of the Opportunistic Bacterial Pathogen…
DOI: http://dx.doi.org/10.5772/intechopen.97004
6. Detection by MALDI-TOF
Matrix-assisted laser desorption/ionisation (MALDI) with time-of-flight 
mass spectrometry (TOFMS) is a technique developed more than three decades 
ago, which can be used to detect and characterise pathogens on the basis of larger 
biomolecules. Few studies proved the feasibility to identify C. concisus using MALDI-
TOF-MS analysis of protein biomarkers from protein extracts of cell lysates or from 
whole cells [59–61]. The first attempt was in 2005 [62] using MALDI-TOF-MS to 
identify a number of Campylobacter species from their protein biomarkers, where 
they have identified a 10.5-kDa protein as the DNA-binding protein HU, and the 
potential species-identifying biomarker ions (SIBI) for C. concisus strains. Later 
this DNA-binding protein HU (10.5-kDa) was suggested to be used as a strain-
specific biomarker for analysis by ‘top-down’ proteomics techniques [59]. However, 
a confirmed C. concisus isolate, by sequencing part of the 16S rRNA gene, could 
not be identified by MALDI-TOF by using database 3995 main spectra (June 2011) 
[63]. While a score ≥ 2.0 is considered reliable species identification, and between 
1.7 and 2.0 represent reliable identification at the genus level, the isolate had only 
a score of 1.62, as C. concisus was not included in the database. The first successful 
identification and characterisation of C. concisus by MALDI-TOF and ClinProTools 
2.2 software was in 2016 [60]. The study correctly identified all 14 C. concisus strains, 
despite evident differences between the isolates, with a scores ≥2.0 for secure species 
identification. There was a clear separation between other Campylobacter species and 
C. concisus by grouping of MSP dendrogram, with sufficient conserved peaks found 
for species identification. However, no distinguished biomarker has been identified 
to differentiate between the two genomospecies which can be easily differentiated 
by the 23S rDNA PCR [28]. Recently the lipo-oligosaccharide (LOS) structure (an 
important virulence factor which activates TLR4) of C. concisus clinical isolates 
correlated the inflammatory potential of each isolate with bacterial virulence by 
MALDI-TOF MS [61]. The presence of multiple bands in the SDS-PAGE profiles of 
C. concisus and C. jejuni LOS indicated their heterogeneity. The mass spectrometric 
analyses of lipid A indicated a novel hexa-acylated diglucosamine moiety, which 
cloud be an indicator of a potential virulence property.
7. Diversity of strains
As C. concisus is a genetically diverse organism, there is no standard molecular 
method yet to fully address this diversity. The standard typing of C. concisus could 
determine whether isolates obtained from diarrhoeic or IBD patients differ from 
those colonising healthy individuals [7, 64–66]. Applying such standard typing 
methods would help researchers to have a better understanding of C. concisus trans-
mission, natural habitat, virulence and the host’s immunological responses [67].
7.1 Typing by protein profiling techniques
It has been suggested that sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) and immunotyping were excellent tools for C. concisus 
identification. SDS-PAGE has been applied successfully to distinguish C. concisus 
from other small bacteria with very similar characteristics, such as C. mucosalis, 
other species of Gram-negative rods, as well as non-pigmenting and asaccharolytic 
bacteria [68, 69]. Other studies have used SDS-PAGE to identify clusters within 
C. concisus; the number of clusters identified varied from two to five [28, 65]. 
Therefore, the protein profiling technique could be discriminative for C. concisus 
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isolates, but the discriminative power might be improved if combined with another 
typing technique such as genotyping. It should also be noted that protein profiling 
failed to separate C. concisus isolates from IBD patients and healthy controls [43].
7.2 Genomic typing by PCR and other techniques
There is no documented standard technique for genotyping C. concisus isolates. The 
first genetic method to type C. concisus was DNA–DNA hybridization [21]. The authors 
used electrophoretic protein profiles, immunotyping and DNA: DNA hybridization to 
identify 22 strains named as EF (E Falsen) group 22 which were identified as C. conci-
sus. The 22 strains showed a considerable heterogeneity (42%) with the C. concisus type 
strain. The genetic diversity was later confirmed by analysis of 100 C. concisus isolates 
using randomly amplified polymorphic DNA (RAPD) [29, 70]. Another approach, 
which is a modification of the 23S rDNA PCR amplification method of Bastyns et al. 
[57], was used successfully used to type C. concisus by Istivan et al. using either the 
specific primer set (MUC1 and CON1) or (MUC1 and CON2) [28, 46]. In this system, 
isolates amplified by MUC1 and CON1 were assigned to genomospecies A while those 
amplified by MUC1 and CON2 were designated as genomospecies B [28, 66, 71].
The multi-locus sequence typing (MLST) was another technique applied to type 70 
oral and intestinal C. concisus isolates from 8 patients with IBD and 6 healthy controls 
[43]. Subsequently, the neighbour-joining tree divided these isolates into 26 types and 
two major groups. Most isolates (87.5%) in cluster 1 were from IBD patients compared 
with only 28.6% in cluster 2 (P < 0.05). It was also reported that all of the invasive C. 
concisus isolates were localised in cluster 1 [43]. Two major groups were also demon-
strated by MLST using a different set of housekeeping genes (aspA, atpA, glnA, gltA, 
glyA, ilvD, and pgm), applied to 60 C. concisus faecal isolates [72]. However, in both of 
these studies, it was not clear whether the two major groups were correlated with geno-
mospecies A and B. A more recent study in 2016, Nielsen et al. [60] determined the 
genetic diversity of 67 C. concisus isolates from Danish diarrheic patients using MLST 
and specific differences in the 23S rRNA, and reported the high diversity of C. concisus 
with 53 sequence types (STs). However, dendrogram profiles of each allele showed a 
division into two groups, which was more or less correlated with genomospecies A and 
genomospecies B but had no association to the clinical severity of disease.
In addition to the previous techniques, the pulsed field gel electrophoresis 
(PFGE) indicated the diversity of C. concisus isolates and assigned them into two 
groups according to the source of the isolates (faeces and oral cavity) and into several 
subgroups [73]. Furthermore, C. concisus isolates have been allocated into four groups 
using the amplified fragment length polymorphism analysis technique (AFLP) [66, 
71]. AFLP groups 1 and 2 aligned with genomospecies A and B (based on 23S rDNA 
PCR); while groups 3 and 4 could not be amplified by 23S rDNA PCR [66].
7.3 Typing by denaturing gradient gel electrophoresis (DGGE)
The PCR-DGGE technique was initially used to evaluate the microbial diver-
sity in complex environments [5]. In environmental microbiology applications, 
universal primers are designed to target the 16S rDNA gene for the detection of 
mixed bacterial communities and differentiation of Campylobacter, Helicobacter and 
Arcobacter from clinical samples and C. concisus [5]. The PCR product is separated 
by polyacrylamide gel electrophoresis based on the use of different melting tem-
peratures and its mobility in gradient denaturation of formamide and urea [74]. 
Previously, the DGGE technique was applied on 21 C. jejuni and one C. coli isolates 
using primer sets targeting the flagellin gene (fla-DGGE) [75]. A study conducted 
on DNA extracted from human saliva using PCR-DGGE to detect Epsilobacteria 
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(Campylobacters, Helicobacters and Arcobacters and related bacteria) reported 
that three reference C. concisus strains fell into two different DGGE profile groups 
[5]. However, Cornelius et al. [76] assigned C. concisus isolates from healthy volun-
teers and diarrhoea specimens into only one DGGE profile group by a semi-nested 
PCR-DGGE from 16S rRNA gene. The authors suggested that PCR-DGGE can be a 
useful tool for a direct detection of Epsiloproteobacteria.
Elshagmani [77] used Muyzer primer sets (518R: R-ATTACCGCGGCTGCTGG;  
341F-GC: F-CCTACGGGAGGCAGCAG and 907R: R-CCGTCAATTCMT 
TTGAGTTT) [78, 79] to amplify the 16S DNA of C. concisus. Those primers were 
originally designed to detect and analyse the genetic diversity of mixed bacte-
rial populations in environmental samples. As the DNA of all C. concisus tested 
isolates could be amplified using both Muyzer primer sets (1 and 2) to amplify 
16S rDNA, it was suggested these sets could be used in clinical samples to detect 
C. concisus in mixed extracted DNA samples. Moreover, the analysis showed that 
all Campylobacter spp. isolates can be divided into four distinct groups that were 
defined as group I, II, III and IV. All C. concisus genomospecies B isolates fall into 
group II consistently, however, most genomospecies A isolates were allocated to 
group I but some were allocated in group II [77].
7.4 Typing by rrn analysis
The diversity of the ribosomal RNA (rrn) operon (5S rRNA, 16S rRNA, 23S 
rRNA genes, and the ITS regions) is considered a useful tool for differentiation of 
the heterogeneous C. concisus species [80]. The sequences of C. concisus rrn operons 
were used in a recent study for the purpose of strain typing and delineation of 
phylogenetic relationships within these operons. A total of 38 indels were identified 
in the rrn operon within C. concisus genome. Five indels found in the 23S rRNA gene 
were significantly associated with either genomospecies A or B (p ≤ 0.05). The 
phylogenetic trees generated from 15 rrn operons and 23S rRNA genes also dem-
onstrated sequence differences between strains within the rrn. Hence, the study 
confirmed that C. concisus can be classified into two genomospecies (A& B) based 
on the presence of the indels in the rrn operon and the 23S rRNA gene is a more 
reliable target for C. concisus typing than the 16S rRNA gene [80].
7.5 Whole genome sequencing
Whole-genome sequencing (WGS) is becoming increasingly available and afford-
able technique. Until 2011, there was only one C. concisus fully sequenced genome 
available for a strain (id. 13826) isolated from faeces of acute gastroenteritis patient 
and sequenced in 2007. The second C. concisus strain (UNSWCD) isolated from an 
intestinal biopsy of a patient with Crohn’s disease was sequenced in 2011 [81]. Only 
76% of genes were homologues between C. concisus 13826 and UNSWCD [82]. More 
C. concisus strains isolated from various clinical sources were sequenced and their 
genomes showed evidence of gene shuffling in C. concisus [83]. Few years later, another 
study defined the C. concisus core-genome and identified genomospecies-specific 
genes [84]. It concluded that the C. concisus core-genome, housekeeping genes, and the 
23S rRNA gene consistently divided the 36 strains used in the study into two genomo-
species. The study also reported novel genomic islands that contain type IV secretion 
system and putative effector proteins, in addition to other new genomic features. A 
study by our team investigated the rrn operon (5S rRNA, 16S rRNA, 23S rRNA genes, 
and the ITS regions) for four newly sequenced whole genomes extracted from intesti-
nal and oral C. concisus strains, along with eight available WGSs online and established 
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More recently, the complete genome sequence of the C. concisus type strain 
ATCC 33237 and the draft genome sequences of eight additional well-characterised 
C. concisus strains were added to the database [85]. This was followed by a 
study in 2018 which analysed the genomes of 63 oral C. concisus strains isolated 
from patients with IBD and healthy controls, of which 38 genomes were newly 
sequenced. The genomes were examined to identify pathogenic molecular mark-
ers and the researchers reported a C. concisus molecular marker, which is a novel 
secreted enterotoxin B homologue (csep1-6bpi) potentially associated with active 
CD [86]. Moreover, in 2018 [87], a study to identify C. concisus virulence proper-
ties and adaptations capability to reside in the GI tract, produced robust genome 
sequencing data and comprehensive pangenome assessment from 53 new C. concisus 
strains. The researchers identified few genetic differences between oral and gut 
isolates from the same patient and suggested that the variability in bacterial secre-
tion system content may play an important role in their virulence potential [87].
8. Conclusion
This chapter discussed the various approaches used to identify and differentiate 
C. concisus, since it was identified and named almost 40 years ago. This bacterium 
has been associated with periodontal diseases, acute enteritis, and IBDs, with the 
strongest evidence relating to acute and chronic intestinal diseases. However, its 
identification has always been challenging due to its inert biochemical charac-
teristics and to the extremely high degree of genetic heterogeneity. The studies 
presented and explored in this chapter show that C. concisus is a genetically diverse 
species, but the extent of the difference between strains remains largely unknown. 
However, with the limitation of biochemical tests to identify C. concisus, molecular 
detection approaches including the PCR, of 23S rDNA, DGGE, m-PCR, MALDI-
TOF and whole genome sequencing, have all made the identification and differen-
tiation of this bacterium much easier than before.
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